-
1دورية أكاديمية
المؤلفون: Min-Hsiang Chuang1, Yu-Shuo Tang2,3, Jui-Yi Chen4,5, Heng-Chih Pan6, Hung-Wei Liao2,7, Wen-Kai Chu8, Chung-Yi Cheng2,3,7 94426@w.tmu.edu.tw, Wu, Vin-Cent9, Michael Heung10 mheung@med.umich.edu
المصدر: Diabetes & Metabolism Journal. Mar2024, Vol. 48 Issue 2, p242-252. 32p.
مصطلحات موضوعية: *SODIUM-glucose cotransporter 2 inhibitors, *GLOMERULAR filtration rate, *DAPAGLIFLOZIN, *TREATMENT effectiveness
-
2دورية أكاديمية
المؤلفون: Ye Seul Yang, Nam Hoon Kim, Jong Ha Baek, Seung-Hyun Ko, Jang Won Son, Seung-Hwan Lee, Sang Youl Rhee, Soo-Kyung Kim, Tae Seo Sohn, Ji Eun Jun, In-Kyung Jeong, Chong Hwa Kim, Keeho Song, Eun-Jung Rhee, Junghyun Noh, Kyu Yeon Hur
المصدر: Diabetes & Metabolism Journal; Mar2024, Vol. 48 Issue 2, p279-289, 14p
مصطلحات موضوعية: TYPE 2 diabetes, PHYSICIAN practice patterns, CARDIOVASCULAR diseases, SODIUM-glucose cotransporter 2 inhibitors, GLUCAGON-like peptide 1
مصطلحات جغرافية: SOUTH Korea
-
3دورية أكاديمية
المؤلفون: Gwanpyo Koh
المصدر: Diabetes & Metabolism Journal; Mar2024, Vol. 48 Issue 2, p208-212, 5p
مصطلحات موضوعية: SODIUM-glucose cotransporters, GLUCAGON-like peptide-1 agonists, DIABETIC nephropathies, MYOCARDIAL infarction, DIABETES, TYPE 2 diabetes, SODIUM-glucose cotransporter 2 inhibitors, TREATMENT effectiveness
-
4دورية أكاديمية
المؤلفون: Jae-Han Jeon1 jeonjh@knu.ac.kr
المصدر: Diabetes & Metabolism Journal. Mar2024, Vol. 48 Issue 2, p213-214. 2p.
مصطلحات موضوعية: *STROKE, *SODIUM-glucose cotransporter 2 inhibitors, *GLUCAGON-like peptide-1 agonists, *DIABETES, *SODIUM-glucose cotransporters, *EMPAGLIFLOZIN, *TYPE 2 diabetes
-
5دورية أكاديمية
المؤلفون: Kyung Ah Han, Yong Hyun Kim, Doo Man Kim, Byung Wan Lee, Suk Chon, Tae Seo Sohn, In Kyung Jeong, Eun-Gyoung Hong, Jang Won Son, Jae Jin Nah, Hwa Rang Song, Seong In Cho, Seung-Ah Cho, Kun Ho Yoon
المصدر: Diabetes & Metabolism Journal; Nov2023, Vol. 47 Issue 6, p796-807, 12p
مصطلحات موضوعية: TYPE 2 diabetes, DAPAGLIFLOZIN, METFORMIN, SODIUM-glucose cotransporter 2 inhibitors, GLYCOSYLATED hemoglobin
-
6دورية أكاديمية
المؤلفون: Jong Ha Baek1, Ye Seul Yang2, Seung-Hyun Ko3, Kyung Do Han4, Jae Hyeon Kim5, Min Kyong Moon6, Jong Suk Park7, Byung-Wan Lee7, Tae Jung Oh8, Suk Chon9, Jong Han Choi10, Kyu Yeon Hur5 hurky73@gmail.com
المصدر: Diabetes & Metabolism Journal. Sep2022, Vol. 46 Issue 5, p701-712. 12p.
مصطلحات موضوعية: *SODIUM-glucose cotransporter 2 inhibitors, *TYPE 2 diabetes, *KOREANS, *CARDIOVASCULAR diseases, *ALDOSTERONE antagonists, *SODIUM-glucose cotransporters, *INCOME
-
7دورية أكاديمية
المؤلفون: Seung Eun Lee1, Hyewon Nam2, Han Seok Choi1, Hoseob Kim2, Dae-Sung Kyoung2, Kyoung-Ah Kim1 kyoung-ah.kim@dumc.or.kr
المصدر: Diabetes & Metabolism Journal. Jul2022, Vol. 46 Issue 4, p567-577. 11p.
مصطلحات موضوعية: *SODIUM-glucose cotransporter 2 inhibitors, *TYPE 2 diabetes, *STROKE patients, *MAJOR adverse cardiovascular events, *NATIONAL health insurance, *ALDOSTERONE antagonists, *ALTEPLASE
-
8دورية أكاديمية
المؤلفون: Nam Hoon Kim1, Nan Hee Kim1 nhkendo@gamil.com
المصدر: Diabetes & Metabolism Journal. Jul2022, Vol. 46 Issue 4, p543-551. 9p.
مصطلحات موضوعية: *SODIUM-glucose cotransporters, *SODIUM-glucose cotransporter 2 inhibitors, *DIABETIC nephropathies, *PROXIMAL kidney tubules, *HEMODYNAMICS, *CHRONIC kidney failure
-
9دورية أكاديمية
المؤلفون: Ji-Yeon Lee1, Minyoung Lee1, Ji Young Lee2,3, Jaehyun Bae1, Eugene Shin3, Yong-ho Lee1,3, Byung-Wan Lee1,3, Eun Seok Kang1,3, Bong-Soo Cha1,3 bscha@yuhs.ac
المصدر: Diabetes & Metabolism Journal. Nov2021, Vol. 45 Issue 6, p921-932. 12p.
مصطلحات موضوعية: *SODIUM-glucose cotransporter 2 inhibitors, *SODIUM-glucose cotransporters, *BROWN adipose tissue, *IPRAGLIFLOZIN, *PROTEIN kinases, *ADIPOSE tissues, *FATTY liver
-
10دورية أكاديمية
المؤلفون: Jun Sung Moon, Nam Hoon Kim, Jin Oh Na, Jae Hyoung Cho, In-Kyung Jeong, Soon Hee Lee, Ji-Oh Mok, Nan Hee Kim, Dong Jin Chung, Jinhong Cho, Dong Woo Lee, Sun Woo Lee, Kyu Chang Won
المصدر: Diabetes & Metabolism Journal; Jan2023, Vol. 47 Issue 1, p82-91, 10p
مصطلحات موضوعية: TYPE 2 diabetes, KOREANS, EMPAGLIFLOZIN, SODIUM-glucose cotransporter 2 inhibitors, GLYCOSYLATED hemoglobin, DYSLIPIDEMIA, HYPERGLYCEMIA